Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis

MLA

Goubet, Anne-Gaëlle, et al. “Prolonged SARS-CoV-2 RNA Virus Shedding and Lymphopenia Are Hallmarks of COVID-19 in Cancer Patients with Poor Prognosis.” Cell Death and Differentiation, vol. 28, no. 12, Dec. 2021, pp. 3297–315. EBSCOhost, https://doi.org/10.1038/s41418-021-00817-9.

APA

Goubet, A.-G., Dubuisson, A., Geraud, A., Danlos, F.-X., Terrisse, S., Silva, C. A. C., Drubay, D., Touri, L., Picard, M., Mazzenga, M., Silvin, A., Dunsmore, G., Haddad, Y., Pizzato, E., Ly, P., Flament, C., Melenotte, C., Solary, E., Fontenay, M., … Derosa, L. (2021). Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis. Cell Death and Differentiation, 28(12), 3297–3315. https://doi.org/10.1038/s41418-021-00817-9

Chicago

Goubet, Anne-Gaëlle, Agathe Dubuisson, Arthur Geraud, François-Xavier Danlos, Safae Terrisse, Carolina Alves Costa Silva, Damien Drubay, et al. 2021. “Prolonged SARS-CoV-2 RNA Virus Shedding and Lymphopenia Are Hallmarks of COVID-19 in Cancer Patients with Poor Prognosis.” Cell Death and Differentiation 28 (12): 3297–3315. doi:10.1038/s41418-021-00817-9.